Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
Non Interventional Study in Slovak Patients With Primary Open Angle Glaucoma and/or Ocular Hypertension Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy Due to Ineffectivity or Intolerance.
1 other identifier
observational
457
1 country
39
Brief Summary
This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2008
Shorter than P25 for all trials
39 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 19, 2008
CompletedFirst Posted
Study publicly available on registry
December 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFebruary 18, 2021
June 1, 2011
8 months
November 19, 2008
February 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of ocular hyperemia
12 months
safety of treatment
12 months
Secondary Outcomes (1)
effectiveness in IOP lowering
12 months
Study Arms (1)
Xalacom treatment
patients with primary glaucoma
Interventions
Eligibility Criteria
Patients \>18 years with primary open angle glaucoma or ocular hypertension
You may qualify if:
- primary open angle glaucoma
- ocular hypertension
- age \>18 years
You may not qualify if:
- bradycardia
- obstructive pulmonary disease
- hypersensitivity to the drug
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (39)
Pfizer Investigational Site
Banovce N. Bebravou, 957 01, Slovakia
Pfizer Investigational Site
Banská Bystrica, 975 17, Slovakia
Pfizer Investigational Site
Bojnice, 972 01, Slovakia
Pfizer Investigational Site
Bratislava, 811 05, Slovakia
Pfizer Investigational Site
Bratislava, 820 07, Slovakia
Pfizer Investigational Site
Bratislava, 833 01, Slovakia
Pfizer Investigational Site
Bratislava, 851 04, Slovakia
Pfizer Investigational Site
Brezno, 977 01, Slovakia
Pfizer Investigational Site
Dunajská Streda, Slovakia
Pfizer Investigational Site
Galanta, Slovakia
Pfizer Investigational Site
Kežmarok, 060 01, Slovakia
Pfizer Investigational Site
Košice, 040 01, Slovakia
Pfizer Investigational Site
Košice, 04004, Slovakia
Pfizer Investigational Site
Krompachy, 053 42, Slovakia
Pfizer Investigational Site
Lipany, 080 01, Slovakia
Pfizer Investigational Site
Lučenec, 984 01, Slovakia
Pfizer Investigational Site
Martin, 036 01, Slovakia
Pfizer Investigational Site
Myjava, 907 13, Slovakia
Pfizer Investigational Site
Nitra, Slovakia
Pfizer Investigational Site
Nová Baňa, 968 01, Slovakia
Pfizer Investigational Site
Nove Mesto N. Vahom, 915 01, Slovakia
Pfizer Investigational Site
Nové Zámky, Slovakia
Pfizer Investigational Site
Poprad, 058 01, Slovakia
Pfizer Investigational Site
Prešov, 080 01, Slovakia
Pfizer Investigational Site
Rimavská Sobota, 979 01, Slovakia
Pfizer Investigational Site
Rožňava, 048 01, Slovakia
Pfizer Investigational Site
Ružomberok, 034 01, Slovakia
Pfizer Investigational Site
Sabinov, 083 01, Slovakia
Pfizer Investigational Site
Sliač, 962 31, Slovakia
Pfizer Investigational Site
Snina, 06901, Slovakia
Pfizer Investigational Site
Spišská Nová Ves, 052 01, Slovakia
Pfizer Investigational Site
Stará Ľubovňa, 064 01, Slovakia
Pfizer Investigational Site
Stará Turá, 916 01, Slovakia
Pfizer Investigational Site
Šaľa, Slovakia
Pfizer Investigational Site
Topoľčany, 955 01, Slovakia
Pfizer Investigational Site
Zlaté Moravce, Slovakia
Pfizer Investigational Site
Zvolen, 960 01, Slovakia
Pfizer Investigational Site
Žiar nad Hronom, 965 01, Slovakia
Pfizer Investigational Site
Žilina, 010 01, Slovakia
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2008
First Posted
December 3, 2008
Study Start
October 1, 2008
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
February 18, 2021
Record last verified: 2011-06